Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Phlebotomy Dependent Polycythemia Vera
Clinical Trial
NCT05143957Last updated: 12/4/2025
IONS
Ionis Pharmaceuticals, Inc.